These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7675644)

  • 1. [Dopamine-D2 receptor scintigraphy with 123I-iodobenzofuran in malignant melanoma].
    Steinert H; Huch-Böni RA; Böni R; Westera G; Buck A
    Nuklearmedizin; 1995 Aug; 34(4):146-50. PubMed ID: 7675644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin.
    Böni R; Steinert H; Böni RA; Lichtensteiger W; Dummer R; Hartman DS; von Schulthess GK; Burg G; Westera G
    Dermatology; 1996; 193(3):198-202. PubMed ID: 8944340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.
    Ichise M; Ballinger JR; Tanaka F; Moscovitch M; St George-Hyslop PH; Raphael D; Freedman M
    J Nucl Med; 1998 Sep; 39(9):1511-8. PubMed ID: 9744333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Henker C; Bida B; Markwardt J; Schlag P
    Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A; Westera G; Sutter M; Albani C; Kung HF; vonSchulthess GK
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
    Laruelle M; van Dyck C; Abi-Dargham A; Zea-Ponce Y; Zoghbi SS; Charney DS; Baldwin RM; Hoffer PB; Kung HF; Innis RB
    J Nucl Med; 1994 May; 35(5):743-54. PubMed ID: 8176454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects.
    Ichise M; Ballinger JR; Vines D; Tsai S; Kung HF
    J Nucl Med; 1997 Jan; 38(1):31-7. PubMed ID: 8998145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
    Kung MP; Kung HF; Billings J; Yang Y; Murphy RA; Alavi A
    J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas.
    Bodei L; Hofland LJ; Ferone D; Mooy CM; Kros JM; Paridaens DA; Baarsma SG; Ferdeghini M; Van Hagen MP; Krenning EP; Kwekkeboom DJ
    Cancer Biother Radiopharm; 2003 Dec; 18(6):895-902. PubMed ID: 14969602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.
    Baldwin RM; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Seibyl JP; Sybirska EH; Malison RT; Laruelle M; Charney DS; Hoffer PB
    Nucl Med Biol; 1994 Oct; 21(7):969-76. PubMed ID: 9234352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating Dopamine D2 receptor with SPECT (II); pharmacokinetics study and quantification in the brain].
    Yonekura Y; Sadato N; Tsuchida T; Uematsu H; Nakamura S; Onishi Y; Yamamoto K; Ishii Y
    Kaku Igaku; 1999 Feb; 36(2):155-68. PubMed ID: 10213983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography.
    Laruelle M; al-Tikriti MS; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Charney DS; Hoffer PB; Kung HF; Innis RB
    Eur J Pharmacol; 1994 Sep; 263(1-2):39-51. PubMed ID: 7821360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H
    Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
    Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
    Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.